๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest

Search Results

Found 13 results for "japan" across articles, medicines, trials, companies and the glossary

SK Biopharmaceuticals Acquires Epilepsy Candidate Opakalim in 795 Million Dollar Deal
Industry
SK Biopharmaceuticals Acquires Epilepsy Candidate Opakalim in 795 Million Dollar Deal
SK Biopharmaceuticals has secured the global licensing rights to Biohaven's selective Kv7 channel activator opakalim (BHV-7000) in a deal valued at up to $795 million.
30 Aug 2026
FedEx Launches Dedicated Life Sciences Division to Secure Global Pharmaceutical Logistics
Industry
FedEx Launches Dedicated Life Sciences Division to Secure Global Pharmaceutical Logistics
FedEx has consolidated its healthcare logistics capabilities into FedEx Life Sciences, a dedicated business unit led by Nick Gennari that leverages global cold chain centers and real-time monitoring to secure temperature-sensitive pharmaceutical supply chains.
26 Aug 2026
Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Industry
Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
An in-depth analysis of Ireland's โ‚ฌ93.8 billion pharmaceutical and medical exports to non-EU markets. Examining trade data across the United States, UK, Switzerland, and Asia-Pacific, key manufacturing clusters in Cork, Dublin, and Limerick, and the strategic outlook for 2026.
08 Aug 2026
US Pharmaceutical Tariffs Update: Policy Realities, The Stockpile 'Unwind', and Irelandโ€™s Strategic Position
Industry
US Pharmaceutical Tariffs Update: Policy Realities, The Stockpile 'Unwind', and Irelandโ€™s Strategic Position
An in-depth analysis of where US pharmaceutical tariff policies stand in mid-2026 under the Trump administration, analyzing recent CSO export data, inventory stockpiling corrections, MFN agreements, and Irelandโ€™s strategic biopharma position.
29 Jul 2026
Ireland's Biopharma Manufacturing Hub: A Master Guide to Tax, Talent, CDMO Sourcing, and Regulatory Excellence
Biotechnology
Ireland's Biopharma Manufacturing Hub: A Master Guide to Tax, Talent, CDMO Sourcing, and Regulatory Excellence
An in-depth analysis of Ireland's evolution into Europe's second-largest exporter of medicinal products. Discover how a 12.5% tax structure, NIBRT bioprocessing excellence, HPRA regulatory trust, and a thriving CDMO ecosystem make Ireland the premier location for global drug production.
21 Jul 2026
After the Mother of All Deals: A Blueprint for the Ireland-India Pharmaceutical Corridor Under the EU-India FTA
Regulatory Affairs
After the Mother of All Deals: A Blueprint for the Ireland-India Pharmaceutical Corridor Under the EU-India FTA
A commercial-grade blueprint for the Ireland-India pharma corridor under the EU-India FTA: tariffs, HPRA-CDSCO bridges, 2030 projections, policy asks.
18 Jul 2026
Understanding the Common Technical Document (CTD) Structure for Global Regulatory Submissions
Regulatory Affairs
Understanding the Common Technical Document (CTD) Structure for Global Regulatory Submissions
An explanation of the 5 modules of the ICH Common Technical Document (CTD) format required for global drug marketing authorization applications.
30 Jun 2026
The Cascade Effect: How US MFN and IRA Pricing Mandates Are Reshaping Drug Development, Launch Sequencing, and Irelandโ€™s Life Sciences Sector
Pharmaceutical
The Cascade Effect: How US MFN and IRA Pricing Mandates Are Reshaping Drug Development, Launch Sequencing, and Irelandโ€™s Life Sciences Sector
An in-depth analysis of how US Most Favored Nation (MFN) drug pricing proposals and the Inflation Reduction Act (IRA) are forcing pharmaceutical companies to restructure indication sequencing, ex-US launches, and global supply chains.
22 Jun 2026
Eisai Allocates ยฃ48M to UK Cold-Chain Pharma Packaging Hub
Pharmaceutical
Eisai Allocates ยฃ48M to UK Cold-Chain Pharma Packaging Hub
Japanese pharmaceutical company Eisai announces a ยฃ48 million investment at its Hatfield, UK site to establish advanced cold-chain supply and packaging capabilities, supported by the Life Sciences Innovative Manufacturing Fund.
22 Jun 2026
Beyond the Strait: How the US-Iran Peace Deal Will Reshape Irelandโ€™s Pharmaceutical Value Chains in 2026
Industry
Beyond the Strait: How the US-Iran Peace Deal Will Reshape Irelandโ€™s Pharmaceutical Value Chains in 2026
With the US-Iran peace deal signed and the Strait of Hormuz set to reopen, Ireland's pharmaceutical export sector stands to benefit from stabilized global energy tariffs, normalized maritime trade corridors, and renewed multinational capital inflows.
21 Jun 2026
How Most Favored Nation (MFN) Pricing Impacts Drug Development & Launch Planning
Regulatory Affairs
How Most Favored Nation (MFN) Pricing Impacts Drug Development & Launch Planning
An expert analysis of the strategic shifts required in global drug development, indication sequencing, and launch timelines in response to proposed Most Favored Nation pricing and the Inflation Reduction Act.
21 Jun 2026
J-Pharma and Uniphar Advance Nanvuranlat into Global Phase III Trial for Biliary Tract Cancer
Clinical Trials
J-Pharma and Uniphar Advance Nanvuranlat into Global Phase III Trial for Biliary Tract Cancer
Japanese biotech J-Pharma and Ireland-based Uniphar have received FDA alignment to bypass Phase II and advance nanvuranlat (JPH203) directly into a pivotal global Phase III study for second-line biliary tract cancer.
18 Jun 2026
Leading CDMO Companies in Ireland: Your Complete Guide to Contract Manufacturing in 2026
Pharmaceutical
Leading CDMO Companies in Ireland: Your Complete Guide to Contract Manufacturing in 2026
A comprehensive guide to the top CDMO companies in Ireland - from Hovione and Thermo Fisher in Cork to EirGen Pharma in Waterford and HiTech Health in Galway. Full profiles, capabilities, certifications, and facilities of Ireland's leading contract development and manufacturing organizations.
16 Jun 2026